Press Releases
Press Release
27/09/2024
Eye on the Cure podcast
The Eye on the Cure Podcast from the Foundation Fighting Blindness provides science information, news, and insights from the world of vision and retinal diseases. Dr. Zuhal Butuner discuss the future of our innovative therapies, sepofarsen for LCA10 and ultevursen for USH2A.
Learn more
Press Release
02/05/2024
Announcement of the creation of Sepul Bio Business Unit
Théa, the leading European eye care group , is pleased to announce the creation of Sepul Bio, a business unit dedicated to the development of inherited retinal diseases (IRDs) based on RNA therapy. Operated by experts in the field, Sepul Bio is in charge of the late stage development of two cutting edge ophthalmic products recently acquired from ProQR , Sepofarsen and Ultevursen, and will work with Théa's teams to support all aspects of the project.
Learn more